Progressed Thyroid Cancer clinical trials

Explore recruiting progressed thyroid cancer clinical trials.

Also recruiting in Europe

Progressed Thyroid Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy

Romania, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Progressed Thyroid Cancer trials by city

Progressed Thyroid Cancer in Toronto Progressed Thyroid Cancer in Vancouver Progressed Thyroid Cancer in Montreal Progressed Thyroid Cancer in Calgary Progressed Thyroid Cancer in Edmonton Progressed Thyroid Cancer in Ottawa Progressed Thyroid Cancer in Winnipeg Progressed Thyroid Cancer in Quebec City Progressed Thyroid Cancer in Hamilton Progressed Thyroid Cancer in Kitchener Progressed Thyroid Cancer in London Progressed Thyroid Cancer in Halifax Progressed Thyroid Cancer in New York Progressed Thyroid Cancer in Los Angeles Progressed Thyroid Cancer in Chicago Progressed Thyroid Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease